WMJ Vol 123 Issue 5: Aim More Towards the Bed than the Head: A Proof of Concept Pilot Study on a Simple Technique for Keeping Trauma Thoracostomy Tubes Out of Lung Fissures
ABSTRACT
Introduction: Tube thoracostomy (TT) is used to drain the pleural cavity in the setting of both traumatic and nontraumatic pathologies. Literature has shown that inappropriate tube positioning occurs in 30% of patients, including TTs placed within the fissure, which may result in further interventions in these patients. Our goal was to compare the rates of TT placed into a lung fissure in a controlled model using a simple approach to direct the tube more toward the bed than the patient's head at the time of placement to validate further investigations of the clinical applicability of this technique.
Methods: We performed 650 tube thoracostomies in 3 separate cadaver torsos with tracheal intubation and bag valve mask approximating a 50% pneumothorax. TTs were performed by experienced clinicians using a "more toward the head" direction and a "more toward the bed" direction while varying other factors, including side of the chest, tube size, and location on the chest wall, followed by lung re-expansion to better evaluate each approach in different common clinical scenarios. A power analysis was performed for our primary outcome of tube placement in a lung fissure by direction, not for any additional variables. Multivariate analysis was used to determine whether the "head" or "bed" direction was more likely to result in tube placement in a fissure when controlling for other changes.
Results: A total of 650 TTs were placed in 3 cadavers by 2 experienced performers. The overall rate of tube placement in a fissure was 41% using the "head" direction and 13% using the "bed" direction. On multivariate analysis, the "bed" direction also was shown to have significantly decreased tube placement in a lung fissure when controlling for side, tube size, and location (P< 0.01; odds ratio 0.22; 95% CI, 0.14 - 0.33).
Conclusions: Aiming more toward the bed than toward the head during TT placement is associated with a significantly decreased chance of placing the TT within a lung fissure in this highly controlled cadaveric proof-of-concept model. This technique requires no changes to standard TT placement set-up, time, cost, or equipment. We propose that it warrants further investigation as a potential intervention to decrease malpositioned tubes.
Intended Audience
The intended audience for this continuing education activity is healthcare professionals caring for the people of Wisconsin and beyond.
Learning Objectives
As a result of participating in this journal-based activity, healthcare team members will be able to:
- Describe complications associated with placement of a thoracostomy tube (TT) used to drain the pleural cavity of blood or air
- Discuss results of this study examining the rates of TT placed into a lung fissure using the patient's head direction versus the bed direction
- Provide rationale for implementing "more toward the bed" TT placement technique in training and practice.
FACULTY DISCLOSURE
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.
For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
| Name of Individual | Individual's Role in Activity | Financial Relationship Disclosure | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices |
| Marianna Shershneva, MD, PhD | Accreditation Specialist | No relevant relationships with ineligible companies to disclose | No |
| James Eberhard, MFA | Accreditation Specialist | No relevant relationships with ineligible companies to disclose | No |
Jacob Peschman, MD | Author | No relevant relationships with ineligible companies to disclose | No |
| Alec J. Fitzsimmons, MPH | Author | No relevant relationships with ineligible companies to disclose | No |
| Andrew J. Borgert, PhD | Author | No relevant relationships with ineligible companies to disclose | No |
| Carley S. Buisman, CHSE | Author | No relevant relationships with ineligible companies to disclose | No |
| Christine J. Waller, MD | Author | No relevant relationships with ineligible companies to disclose | No |
| Faraz A. Khan, MD | Author | No relevant relationships with ineligible companies to disclose | No |
| Thomas Carver, MD | Reviewer | Cytovale, Inc (Independent Contractor - Consultant), Innovital, Inc (Independent Contractor - Other) | No |
| Amy E. Liepert, MD | Reviewer | No relevant relationships with ineligible companies to disclose | No |
| Fahad Aziz, MD | Editor | No relevant relationships with ineligible companies to disclose | No |
| Katie Gillespie, DNP, RN, CPH, FAAN | Reviewer | No relevant relationships with ineligible companies to disclose | No |
| Cassie Meffert, PAC, MPH | Reviewer | No relevant relationships with ineligible companies to disclose | No |
| David Dwyer, PhD, RN, NEBC | Reviewer | No relevant relationships with ineligible companies to disclose | No |
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients. The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.
Accreditation Statement
| Accreditation Logos | Accreditation Statements |
![]() | In support of improving patient care, this activity has been planned and implemented by the University of Wisconsin–Madison ICEP and the Wisconsin Medical Journal. The University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. |
Credit Designation Statements | |
American Medical Association (AMA)The University of Wisconsin–Madison ICEP designates this journal-based CE activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. | |
American Nurses Credentialing Center (ANCC)The University of Wisconsin–Madison ICEP designates this journal-based CE activity for a maximum of 0.75 ANCC contact hours. | |
Continuing Education UnitsThe University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.075 continuing education units (CEUs) or 0.75 hour. | |
Available Credit
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC Contact Hours
- 0.75 University of Wisconsin–Madison Continuing Education Hours
- 0.75 Approved for AMA PRA Category 1 Credit™
Accessibility
If you need anything to participate in this program, please contact [email protected].
Required Hardware/software
Free, current version of Chrome, Firefox, Safari, or Edge. Some older browsers and Microsoft Internet Explorer could produce error messages or not display the content correctly.
Free, current version of Adobe Acrobat Reader or other .pdf reader.

Facebook
X
LinkedIn
Forward